alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Energy

###### Federal Energy Regulatory Commission

          - [Docket No. AC09-57-000]

Take notice that on April 3, 2009 Trans-Union Interstate Pipeline, L.P. submitted a request for waiver of the requirement to submit the 2008 FERC Form No. 2-A under Section 260.2 of the Commission regulations.

Any person desiring to intervene or to protest this filing must file in accordance with Rules 211 and 214 of the Commission's Rules of Practice and Procedure (18 CFR 385.211, 385.214). Protests will be considered by the Commission in determining the appropriate action to be taken, but will not serve to make protestants parties to the proceeding. Any person wishing to become a party must file a notice of intervention or motion to intervene, as appropriate. Such notices, motions, or protests must be filed on or before the comment date. On or before the comment date, it is not necessary to serve motions to intervene or protests on persons other than the Applicant.

                    The Commission encourages electronic submission of protests and interventions in lieu of paper using the “eFiling” link at                     *http://www.ferc.gov.*                     Persons unable to file electronically should submit an original and 14 copies of the protest or intervention to the Federal Energy Regulatory Commission, 888 First Street, NE., Washington, DC 20426.                

                    This filing is accessible online at                     *http://www.ferc.gov,*                     using the “eLibrary” link and is available for review in the Commission's Public Reference Room in Washington, DC. There is an “eSubscription” link on the Web site that enables subscribers to receive e-mail notification when a document is added to a subscribed docket(s). For assistance with any FERC Online service, please e-mail                     *FERCOnlineSupport@ferc.gov,*                     or call (866) 208-3676 (toll free). For TTY, call (202) 502-8659.                

*Comment Date:*                     May 14, 2009.                

Kimberly D. Bose,

Secretary.

[FR Doc. E9-9086 Filed 4-20-09; 8:45 am]

BILLING CODE 6717-01-P
<PAGE>
                                  EXHIBIT 11.1


                        COMPUTATION OF EARNINGS PER SHARE


<TABLE>
<CAPTION>
                                                           Three Months ended                   Six Months ended
                                                                 June 30,                           June 30,
                                                          2002              2001              2002              2001
                                                       ----------        ----------        ----------        ----------
<S>                                                    <C>               <C>               <C>               <C>
Net income                                             $  816,024        $1,706,406        $2,704,052        $2,812,585
                                                       ==========        ==========        ==========        ==========

Weighted average number of common
  and common equivalent shares

Weighted average common shares outstanding              2,718,370         2,698,746         2,708,612         2,698,746

Shares issued from assumed exercise of
  common stock equivalents(1)                              90,857            19,704            79,153            17,636
                                                       ----------        ----------        ----------        ----------

Weighted average number of common and
  common equivalent shares outstanding                  2,809,227         2,718,450         2,787,765         2,716,382
                                                       ==========        ==========        ==========        ==========
Earnings per share:
         Basic                                         $      .30        $      .63        $     1.00        $     1.04
                                                       ==========        ==========        ==========        ==========

         Diluted                                       $      .29        $      .63        $      .97        $     1.04
                                                       ==========        ==========        ==========        ==========
</TABLE>

(1)      The number of common stock equivalents excluded from the computation of
         earnings per share because they were antidilutive was 82,135 for the
         three months ended June 30, 2001, and 11,007 and 92,925 for the six
         months ended June 30, 2002 and 2001, respectively.
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 2766 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 2766

        To extend the temporary suspension of duty on Lambda-Cy.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 7, 2012

   Mr. Casey introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
        To extend the temporary suspension of duty on Lambda-Cy.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. LAMBDA-CY.

    (a) In General.--Heading 9902.02.09 of the Harmonized Tariff 
Schedule of the United States (relating to mixtures of cyhalothrin and 
application adjuvants) is amended by striking the date in the effective 
period column and inserting ``12/31/2015''.
    (b) Effective Date.--The amendment made by subsection (a) applies 
to goods entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### Centers for Disease Control and Prevention

This gives notice under the Federal Advisory Committee Act (Pub. L. 92-463) of October 6, 1972, that the Interagency Committee on Smoking and Health, Department of Health and Human Services, has been renewed for a 2-year period through March 20, 2011.

For information, contact Ms. Dana Shelton, Executive Secretary, Interagency Committee on Smoking and Health, Department of Health and Human Services, 4770 Buford Highway, M/S K50, Atlanta, Georgia 30341, telephone 770-488-5709, or fax 770-488-5767.

                    The Director, Management Analysis and Services Office, has been delegated the authority to sign                     **Federal Register**                     notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.                

Dated: April 10, 2009.

Elaine L. Baker,

Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.

[FR Doc. E9-8971 Filed 4-16-09; 8:45 am]

BILLING CODE 4163-18-P
Exhibit
32.2





Certification
of Chief Financial Officer


Pursuant
to 18 U.S.C. Section 1350,


as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002





In
connection with the quarterly report of Axion International Holdings, Inc. (the
“Company”) on Form 10-Q for the quarter ended March 31, 2009 as filed with the
Securities and Exchange Commission on the date hereof (the “Report”), I, Michael
W. Johnson, Chief Financial Officer of the Company, certify, pursuant to 18
U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002,
that:





(1)
The Report fully complies with the requirements of section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and





(2)
The information contained in the Report fairly presents, in all material
respects, the financial condition and result of operations of the
Company.





/s/
      Michael W. JohnsonMichael
      W. JohnsonChief
      Financial Officer




May 15,
2009
* Pursuant to 5 TH C IR . R. 47.5, the Court has determined that this opinion should not be published and is not precedent except under the limited circumstances set forth in 5 TH C IR . R. 47.5.4. United States Court of Appeals Fifth Circuit 

### FILED July 5, 2007 Charles R. Fulbruge III Clerk IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

_____________________ No. 06-60702 Summary Calendar

_____________________ WILLIE A. WRIGHT, Petitioner - Appellant,
versus COMMISSIONER OF INTERNAL REVENUE, Respondent - Appellee.

________________________________________________________________________

Appeal from the United States Tax Court Tax Court Docket No. 22905-04

________________________________________________________________________ Before JOLLY, DENNIS, and CLEMENT, Circuit Judges. PER CURIAM: * Willie W. Wright, pro se, appeals an adverse judgment of the Tax Court. He argues that the Tax Court erred in finding that he was not entitled to claim a casualty loss deduction. In 1997, Wright’s home was destroyed by fire. He claimed a casualty loss of $160,402 on his 1997 income tax return forthe destruction of the home and its contents. The Tax Court found that

Wright failed to carry his burden of substantiating a loss in excess of the insurance proceeds that he received, as required by 26 U.S.C. § 165(a). That finding is not clearly erroneous. Wright did not submit evidence of the fair market value of the property immediately before and immediately after the fire, nor did he prove his adjusted basis in the property. The judgment of the Tax Court is, therefore, AFFIRMED.
<PAGE>

                                  EXHIBIT 99.2

                           CERTIFICATION PURSUANT TO
                            18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In connection with the Annual Report of Volume Services America Holdings,
Inc. (the "Company") on Form 10-K for the year ended December 31, 2002 as filed
with the Securities and Exchange Commission on the date hereof (the "Report"),
I, Kenneth R. Frick, Chief Financial Officer of the Company, certify, pursuant
to 18 U.S.C. sec. 1350, as adopted pursuant to sec. 906 of the Sarbanes-Oxley
Act of 2002, that:

          (1)  The Report fully complies with the requirements of section 13(a)
     or 15(d) of the Securities Exchange Act of 1934; and

          (2)  The information contained in the Report fairly presents, in all
     material respects, the financial condition and result of operations of the
     Company.

                                          /s/ KENNETH R. FRICK
                                          --------------------------------------
                                          Kenneth R. Frick
                                          Chief Financial Officer

Date: March 20, 2003

                                        67
Exhibit 31.1 SECTION 302 CERTIFICATION  I, Edwin G. Marshall, certify that:  1. I have reviewed this quarterly report of Medizone International, Inc. for the quarter ended June 30, 2006;  2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;  3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the small business issuer as of, and for, the periods presented in this report;  4. The small business issuer=s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the small business issuer and have: (a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the small business issuer, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; (b) evaluated the effectiveness of the small business issuer=s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and (c) disclosed in this report any change in the small business issuer=s internal control over financial reporting that occurred during the small business issuer=s most recent fiscal quarter (the small business issuer=s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the small business issuer=s internal control over financial reporting; and  5. The small business issuer=s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the small business issuer=s auditors and the audit committee of the small business issuer=s board of directors (or persons performing the equivalent functions): (a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the small business issuer=s ability to record, process, summarize and report financial information; and (b) any fraud, whether or not material, that involves management or other employees who have a significant role in the small business issuer=s internal control over financial reporting.  Date: August 17, 2006  /s/Edwin G. Marshall Edwin G. Marshall, Principal Executive Officer
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED
FROM
THE STATEMENTS OF CONSOLIDATED OPERATIONS AND IS QUALIFIED IN ITS
ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               MAR-31-1999
<CASH>                                      18,126,000
<SECURITIES>                                98,543,000
<RECEIVABLES>                              143,558,000
<ALLOWANCES>                                 8,868,000
<INVENTORY>                                          0
<CURRENT-ASSETS>                           350,856,000
<PP&E>                                     309,336,000
<DEPRECIATION>                              71,742,000
<TOTAL-ASSETS>                           1,034,831,000
<CURRENT-LIABILITIES>                      326,273,000
<BONDS>                                    263,209,000
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                       142,000
<OTHER-SE>                                 291,842,000
<TOTAL-LIABILITY-AND-EQUITY>             1,034,831,000
<SALES>                                              0
<TOTAL-REVENUES>                           318,074,000
<CGS>                                                0
<TOTAL-COSTS>                              309,979,000
<OTHER-EXPENSES>                             5,106,000<F1>
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                           4,049,000
<INCOME-PRETAX>                            (1,060,000)
<INCOME-TAX>                                 (354,000)
<INCOME-CONTINUING>                          (706,000)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (706,000)
<EPS-PRIMARY>                                   (0.03)
<EPS-DILUTED>                                   (0.03)
<FN>
<F1>Impairment and Other Costs
</FN>
        

</TABLE>
**Exhibit 32.1**

**Certification ofQuarterly Report**

I, Gerald McMahon,Chief Executive Officer of Poniard Pharmaceuticals, Inc. (the “Company”),certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18U.S.C. 1350 that:

a.                 the QuarterlyReport on Form 10-Q for the quarter ended June 30, 2007 (the“Report”) fully complies with the requirements of Section 13(a) or15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d));and

b.                theinformation contained in the Report 10-Q fairly presents, in all materialrespects, the financial condition and results of operations of the Company.
| Date: August 9, 2007 | By:    | /s/ GERALD  MCMAHON                      |
|---------------------------|--------|------------------------------------------|
|                      |   | Gerald McMahon *Chief Executive Officer* |

 

----
Exhibit 99.2



Statement of Chief Financial Officer

Pursuant to Section 1350 of Title 18 of the United States Code



Pursuant to Section 1350 of Title 18 of the United States Code, the undersigned, James D. Brown, the Treasurer and Chief Financial Officer
of NutriSystem, Inc. (the Company), hereby certifies that:



| | 1) |  | The Companys Form 10-Q Quarterly Report for the period ended March 31, 2003 (the Report) fully complies with the requirements of Section 13(a) of
the Securities Exchange Act of 1934; and
| | -- |  | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | 2) |  | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | -- |  | ----------------------------------------------------------------------------------------------------------------------------------------------------







|                 
|-----------------
|Date: May 2, 2003
|
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 2982 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 2982

          To suspend temporarily the duty on Neononyl Acetate.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 8, 2012

 Mr. Menendez introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
          To suspend temporarily the duty on Neononyl Acetate.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. NEONONYL ACETATE.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:

``     9902.01.00      3,5,5-trimethylhex  Free         No change        No change        On or before 12/  ''.
                        yl acetate (CAS                                                    31/2015.......
                        No. 58430-94-7)
                        (provided for in
                        subheading
                        2915.39.4550)....

    (b) Effective Date.--The amendment made by subsection (a) applies 
with respect to goods entered, or withdrawn from warehouse for 
consumption, on or after the 15th day after the date of the enactment 
of this Act.
                                 <all>
```